Skip to main content
VCbacked
Log inGet Started

Apogee Therapeutics

San Francisco, United States

Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders.

$1.3B raised
May 2026
Post-IPO Debt
BiotechnologyLife ScienceMedicalTherapeutics

Top Investors

RA Capital ManagementBlackstone Life SciencesWellington ManagementPerceptive AdvisorsOrbiMed

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Apogee Therapeutics

How much funding has Apogee Therapeutics raised?
Apogee Therapeutics has raised $1.3B in total funding. The most recent round was Post-IPO Debt. The last funding was announced in May 2026.
Who are Apogee Therapeutics's investors?
Apogee Therapeutics's investors include RA Capital Management, Blackstone Life Sciences, Wellington Management, Perceptive Advisors, OrbiMed.
Where is Apogee Therapeutics headquartered?
Apogee Therapeutics is headquartered in San Francisco, United States.
What does Apogee Therapeutics do?
Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders.
What stage is Apogee Therapeutics at?
Apogee Therapeutics is at the Post-IPO Debt stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Apogee Therapeutics — Funding & Investors." VCBacked, May 27, 2026, https://www.vcbacked.co/company/apogee-therapeutics. Accessed July 3, 2026.
APA
VCBacked. (2026). Apogee Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/apogee-therapeutics
Wikipedia (cite web)
{{cite web |title=Apogee Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/apogee-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Rapport Therapeutics
Boston$250.0M
Allterum Therapeutics
Houston$1.0M
AlpalifeBio
Woburn$9.8M
Renaissance BioScience
Vancouver$599K
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K